about
Hybrid formulations of liposomes and bioadhesive polymers improve the hypotensive effect of the melatonin analogue 5-MCA-NAT in rabbit eyesOphthalmic formulations of the intraocular hypotensive melatonin agent 5-MCA-NAT.Effects of corneal thickness on the intraocular penetration of travoprost 0.004%.Current Perspectives on the Use of Anti-VEGF Drugs as Adjuvant Therapy in Glaucoma.Recent patents and developments in glaucoma biomarkers.The potential of using biodegradable microspheres in retinal diseases and other intraocular pathologies.Six month delivery of GDNF from PLGA/vitamin E biodegradable microspheres after intravitreal injection in rabbits.Optimising the controlled release of dexamethasone from a new generation of PLGA-based microspheres intended for intravitreal administration.Novel biodegradable polyesteramide microspheres for controlled drug delivery in Ophthalmology.Pharmaceutical microscale and nanoscale approaches for efficient treatment of ocular diseases.Novel anti-inflammatory liposomal formulation for the pre-ocular tear film: In vitro and ex vivo functionality studies in corneal epithelial cells.Preservation of biological activity of glial cell line-derived neurotrophic factor (GDNF) after microencapsulation and sterilization by gamma irradiation.Retinal ganglion cells survival in a glaucoma model by GDNF/Vit E PLGA microspheres prepared according to a novel microencapsulation procedure.Ketorolac Administration Attenuates Retinal Ganglion Cell Death After Axonal Injury.Clinical applications of the sustained-release dexamethasone implant for treatment of macular edema.The effect of preservative-free HP-Guar on dry eye after phacoemulsification: a flow cytometric study.Comparative analysis of carmellose 0.5% versus hyaluronate 0.15% in dry eye: a flow cytometric study.Design and characterization of an ocular topical liposomal preparation to replenish the lipids of the tear film.Novel Water-Soluble Mucoadhesive Carbosilane Dendrimers for Ocular Administration.Evaluation of polyesteramide (PEA) and polyester (PLGA) microspheres as intravitreal drug delivery systems in albino rats.Robust cell integration from co-transplantation of biodegradable MMP2-PLGA microspheres with retinal progenitor cells.Biodegradable ibuprofen-loaded PLGA microspheres for intraarticular administration. Effect of Labrafil addition on release in vitro.Study of gamma-irradiation effects on aciclovir poly(D,L-lactic-co-glycolic) acid microspheres for intravitreal administration.Radiosterilisation of indomethacin PLGA/PEG-derivative microspheres: protective effects of low temperature during gamma-irradiation.Self-assembled particles of an elastin-like polymer as vehicles for controlled drug release.Performance of the rebound, noncontact and Goldmann applanation tonometers in routine clinical practice.Downregulation of endotoxin-induced uveitis by intravitreal injection of polylactic-glycolic acid (PLGA) microspheres loaded with dexamethasone.Random co-polymers based on the poloxamer Bayfit® 10WF15 for biomedical applicationsNovel Nano-Liposome Formulation for Dry Eyes with Components Similar to the Preocular Tear FilmHyaluronic Acid Combined with Serum Rich in Growth Factors in Corneal Epithelial DefectsThe use of mucoadhesive polymers to enhance the hypotensive effect of a melatonin analogue, 5-MCA-NAT, in rabbit eyesBiocompatibility of elastin-like polymer poly(VPAVG) microparticles: in vitro and in vivo studiesComparison of the in vitro tolerance and in vivo efficacy of traditional timolol maleate eye drops versus new formulations with bioadhesive polymers[Comparative study of the pressure lowering efficacy and variations in the ocular pulse amplitude between fixed combinations of dorzolamide/timolol and brinzolamide/timolol]
P50
Q28543935-44E06926-C059-43AB-A308-490488A8B9FAQ34014995-47DD9F53-954A-4092-87A4-65871FF5C167Q36093285-F6F013EC-9FBF-46E3-AABB-6094BF36F7A8Q37672460-B970A360-E708-4F41-941D-AD7BC2CC8601Q38029104-5A6F9A38-C3B4-434A-B568-4515F9AAF337Q38211153-E1A04083-5141-413D-84DA-0A66A9D03E39Q38713896-6A0B2653-F002-4D1B-A2B9-F5EF567B09D7Q38785410-D4DDC863-ADF2-4F7D-941E-C231C570BC1EQ38871711-9912A5FF-8F91-40C6-B49B-5C81ECFF92A5Q38987118-7DAE5ECB-8213-4B68-A3F9-4A8DB300FDE1Q39164171-AF968727-44C7-4569-B1EF-D52A362FB3EFQ39308958-69A301CF-11F6-4535-A487-F6D2EC3F4714Q39518050-01596C9F-42C0-4EA6-98A9-12BAC56724EAQ39922042-CA6B5BE2-5073-48E4-92B3-13EDF1C82D2CQ42633090-86F59706-3D45-4CAE-866E-489AD2067CCFQ43124441-68AFAB39-E557-4B6F-8B38-F80A28E90F60Q43214337-B6C4B9B3-7196-49D2-926E-930AC00766DFQ43325080-1C32C2F4-9048-4464-9255-FD5E23A5B185Q43348780-38497DB8-47B9-4B34-9E13-D5AC98B54DDCQ43359848-32F28606-2BCD-421B-877D-21B81F90ED6BQ44107253-27E351E4-FF32-4F45-8201-C44AA30E905CQ44430180-368C32A4-E024-41BA-B436-E5FBD789602CQ45040606-B501C6F0-9C90-4A46-8E49-8E36784DF4C0Q51263902-0E02F180-3897-46FF-980D-A9341DABBE64Q51553120-E36F346E-023C-4636-9077-3937A4C98069Q53061911-1D471D28-0309-419D-B9C4-6D98CACD0F2AQ54407050-1B136309-AFE1-487A-B5D7-52FC3B50F84CQ57214470-91AE104E-FB20-4FE8-A9F2-A47BADC01564Q57383056-A3577FD7-2B56-47C9-9AAC-FE73AA1B6F53Q64080340-13BEC83B-9CC7-4C08-ACC5-0321B79414DEQ82506649-F2820761-561F-48E9-A468-93676047D1AEQ83216581-896AD359-2061-4F03-A666-5E1E7EF58B24Q83377606-774EB024-C1E6-4912-8343-B0F3DDF787D4Q84225147-400FE0E3-8DF4-47BE-AFAC-3D8BA1E168A4
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Rocío Herrero-Vanrell
@ast
Rocío Herrero-Vanrell
@en
Rocío Herrero-Vanrell
@es
Rocío Herrero-Vanrell
@nl
Rocío Herrero-Vanrell
@sl
type
label
Rocío Herrero-Vanrell
@ast
Rocío Herrero-Vanrell
@en
Rocío Herrero-Vanrell
@es
Rocío Herrero-Vanrell
@nl
Rocío Herrero-Vanrell
@sl
prefLabel
Rocío Herrero-Vanrell
@ast
Rocío Herrero-Vanrell
@en
Rocío Herrero-Vanrell
@es
Rocío Herrero-Vanrell
@nl
Rocío Herrero-Vanrell
@sl
P1053
G-6849-2017
P106
P21
P31
P3829
P496
0000-0001-9764-7975